Skip to content
DE

Acetyl octapeptide-3Cosmetic ingredient

What is Acetyl octapeptide-3?

Acetyl octapeptide-3, commonly marketed as SNAP-8, is a synthetic eight-amino-acid cosmetic peptide used in products for expression lines. It is related to Argireline but is a different ingredient.

Published human research includes microneedle patches containing SNAP-8 alongside other active ingredients. Those preparations differ from ordinary creams and do not reveal the peptide’s individual contribution. 5 6

How it works

The proposed mechanism involves SNAP-25-related signalling and the SNARE machinery that helps nerve cells release chemical messengers. This is a rationale for research, not proof that a SNAP-8 cream reaches facial nerves or relaxes muscles. The retained 2013 Argireline trial tests the related hexapeptide, not this octapeptide. 1

Effects studied

Appearance of eye wrinkles

A 2024 study in 24 participants compared a dissolving microneedle patch containing SNAP-8 and other active ingredients with a hyaluronic-acid-only patch over 28 days. The active combination improved assessed eye-wrinkle and skin measures. The design cannot assign that result to SNAP-8 alone. 5

Evidence: Small comparative study of a multi-ingredient patch

Fine lines and hydration

A 12-week single-centre study of another multi-ingredient microneedle patch reported improvements in fine lines and hydration. The product also contained other peptides, adenosine and seaweed extracts; its results do not establish the effect of SNAP-8 in a serum. 6

Evidence: Combination-product study; ingredient effect unresolved

What does the evidence show?

Human studies have tested multi-ingredient microneedle patches containing SNAP-8. They provide product-level findings but cannot isolate the contribution of acetyl octapeptide-3. They also do not establish the same effect for a conventional cream or superiority over Argireline. 5 6

The proposed target

The ingredient is designed around a fragment of a protein involved in nerve-cell signalling. The proposal is that modifying this signalling could reduce the appearance of expression-related lines. For a topical product, researchers also need to show that the peptide penetrates skin and produces a visible effect in people.

Why Argireline studies cannot answer the question

SNAP-8 and Argireline are frequently discussed together. They are nevertheless distinct ingredients. A controlled trial of acetyl hexapeptide-8 cannot establish the effectiveness of an octapeptide preparation. The retained Argireline paper is useful background, but should not be displayed as direct proof for this ingredient. 1

What a useful comparison would look like

A persuasive study would compare the finished product with an appropriate control, assess a defined area of skin and explain how appearance was measured. A claim that one peptide is stronger than another would additionally need a direct comparison, rather than a comparison of separate supplier experiments.

The rest of the formula matters

Hydration and the other ingredients may account for some of the change someone notices after using a serum. Sensitivity can likewise depend on the full formula. A peptide cream should not be described as an interchangeable substitute for an injected treatment merely because both are discussed in relation to expression lines.

Safety & status

The 2024 patch study reported no adverse effects, and the 12-week study reported no primary or cumulative skin reactions. These findings concern the tested products and study durations; they do not establish long-term safety or safety of injection. 5 6

Skin penetration and tolerability depend on delivery. A dissolving microneedle patch, a leave-on cream and an injectable product should not share a single safety claim.

Country and product status

This page describes a cosmetic ingredient and its research context. Permitted claims and product availability in Germany and Switzerland need a local check. An ingredient listing does not establish approval to treat a medical condition.

Frequently asked questions

Is SNAP-8 stronger than Argireline?

The evidence reviewed here does not establish that. The 2013 Argireline trial and the SNAP-8 combination-patch studies test different products; they are not a direct comparison between the two peptides. 1 5 6

Has SNAP-8 been tested in people?

Yes, as one component of multi-ingredient microneedle patches. These studies are more informative about the complete patch than about SNAP-8 by itself. 5 6

Can patch results predict what a cream will do?

No reliable effect size can be transferred. Microneedles change delivery through the skin, while the tested patches also contain several active ingredients. A cream needs its own relevant comparison. 5

Does it relax facial muscles like an injectable treatment?

That has not been established by the human studies described here. They measured skin appearance and related properties, not an equivalent clinical effect to injected botulinum toxin. 5 6

Is a higher percentage necessarily better?

No concentration-response comparison is established here. A percentage may describe a diluted supplier blend rather than pure peptide, so the actual ingredient concentration and complete formula must be identified before products can be compared.

Further reading

Concept illustration for Acetyl octapeptide-3.GuideAcetyl Octapeptide-3 (SNAP-8)Acetyl Octapeptide-3, also called SNAP-8, is used in cosmetics for expression lines. Reported benefits rely mainly on manufacturer data; independent human studies are limited, and superiority over Argireline has not been established.Read the article

Sources

This entry was rewritten from our research archive. References below are reading leads unless a completed check is explicitly noted; a full independent evidence and regulatory review is still pending.

  1. Wang et al. · Argireline trial: related hexapeptide, not SNAP-8 Research reference · PubMed abstract checked 27 October 2026. This study tests acetyl hexapeptide-8, not acetyl octapeptide-3; background only.
  2. Acetyl octapeptide-3: www.fda.gov reference Reference or product information · Retained archive reference; not independently checked for this draft.
  3. Acetyl octapeptide-3: www.fda.gov reference Reference or product information · Retained archive reference; not independently checked for this draft.
  4. Acetyl octapeptide-3: paper 10.1111/jocd.12314 Research reference · Retained archive reference; not independently checked for this draft.
  5. Shin et al. · Multi-ingredient dissolving microneedle patch (2024) Primary research · Primary abstract checked; 24 participants, 28 days, active combination versus hyaluronic-acid patch. Does not isolate SNAP-8. Checked 27 October 2026.
  6. Avcil et al. · Peptide-loaded hyaluronic-acid microneedle patches (2020) Primary research · Primary abstract checked; 12-week single-centre multi-ingredient study. No isolated SNAP-8 effect established. Checked 27 October 2026.
Research provenance

This name was discovered in the Superpower peptide index, archived 26 October 2026. Its ratings and reviewer attribution have not been adopted as our own. The archive informed this original editorial draft; independent source review is still pending.